ContraFect Announces Restructuring, CEO Resigns
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ContraFect Corp (CFRXQ)
ContraFect Corp stock price live, this page displays OTC CFRXQ stock exchange data. View the CFRXQ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ContraFect Corp real time stock price chart below.
What Is the ContraFect Corp Stock Price Today?
The ContraFect Corp stock price today is 0.140.
What Is the Stock Symbol for ContraFect Corp?
The stock ticker symbol for ContraFect Corp is CFRXQ.
Is CFRXQ the Same as $CFRXQ?
$CFRXQ is a common way to refer to the ContraFect Corp ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does ContraFect Corp Trade On?
ContraFect Corp is listed and trades on the OTC Markets stock exchange.
Is ContraFect Corp a Good Stock to Buy?
Determining whether ContraFect Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current ContraFect Corp share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CFRXQ quote. (ISIN: US2123264093)
What Is the ContraFect Corp Stock Price Today?
The ContraFect Corp stock price today is 0.140.
What Is the Stock Symbol for ContraFect Corp?
The stock ticker symbol for ContraFect Corp is CFRXQ.
Is CFRXQ the Same as $CFRXQ?
$CFRXQ is a common way to refer to the ContraFect Corp ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does ContraFect Corp Trade On?
ContraFect Corp is listed and trades on the OTC Markets stock exchange.
Is ContraFect Corp a Good Stock to Buy?
Determining whether ContraFect Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current ContraFect Corp share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CFRXQ quote. (ISIN: US2123264093)
OTC Markets
Currency in USD
0.140
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.140
0.140
52 wk Range
0.001
0.140
CFRXQ Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week High
More Info
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1400.140
52 wk Range
0.0010.140
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CFRXQ Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- ContraFect Announces $15M Share Offering
- Investing.com
- ContraFect Announces Restructuring, CEO Resigns
- Investing.com
- ContraFect Announces $15M Share Offering
- Investing.com
ContraFect Corp Company Profile
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus. The company also developing CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also developing CF-296, an osteomyelitis and PJI which is in preclinical trailers for the treatment of joint infections. In addition, the company developing Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. Further, It develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. On December 4, 2023, ContraFect Corporation filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Compare CFRXQ to Peers and Sector
Metrics to compare | CFRXQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCFRXQPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −4.0x | −0.5x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price / Book | 0.0x | 1.9x | 2.6x | |
Price / LTM Sales | 0.0x | 22.6x | 3.0x | |
Upside (Analyst Target) | 0.0% | 174.0% | 49.2% | |
Fair Value Upside | Unlock | 13.4% | 7.4% | Unlock |
Earnings
Latest Release
Nov 14, 2023
EPS / Forecast
-0.50 / -0.66
Revenue / Forecast
-- / --
FAQ
What Is the ContraFect Corp (CFRXQ) Stock Price Today?
The ContraFect Corp stock price today is 0.14
What Stock Exchange Does ContraFect Corp Trade On?
ContraFect Corp is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for ContraFect Corp?
The stock symbol for ContraFect Corp is "CFRXQ."
What Is the ContraFect Corp Market Cap?
As of today, ContraFect Corp market cap is 1.50M.
What Is ContraFect Corp's Earnings Per Share (TTM)?
The ContraFect Corp EPS (TTM) is -5.58.
From a Technical Analysis Perspective, Is CFRXQ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has ContraFect Corp Stock Split?
ContraFect Corp has split 2 times.
How Many Employees Does ContraFect Corp Have?
ContraFect Corp has 23 employees.
What is the current trading status of ContraFect Corp (CFRXQ)?
As of Jul 08, 2025, ContraFect Corp (CFRXQ) is trading at a price of 0.14, with a previous close of 0.00. The stock has fluctuated within a day range of 0.14 to 0.14, while its 52-week range spans from 0.00 to 0.14.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.